Skip to main content
OpenTrials

Clinical trial condition

Clear-cell metastatic renal cell carcinoma

Explore clinical trials studying Clear-cell metastatic renal cell carcinoma. Study availability and eligibility vary by location and protocol.

54 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Clear-cell metastatic renal cell carcinoma trial results

Completed

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

NCT03679767

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. Fresno, California, United States
  • California Cancer Associates for Research and Excellence Fresno, California, United States
  • California Cancer Associates for Research and Excellence, Inc. San Marcos, California, United States
  • St Joseph Heritage Healthcare Santa Rosa, California, United States
View all 52 locations
View Trial Details
Completed

Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma

NCT02917772

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Ordensklinikum Linz Barmherzige Schwestern Linz, Austria
  • AKH Wien Universitätsklinik für Innere Medizin I Vienna, Austria
  • ZNA Middelheim Antwerp, Belgium
  • CHR Verviers Verviers, Belgium
View all 35 locations
View Trial Details
Completed

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

NCT01472081

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • City Of Hope Duarte, California, United States
  • Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 14 locations
View Trial Details
Completed

MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma

NCT02724020

Conditions
Clear-cell Metastatic Renal Cell Carcinoma, Clear-cell metastatic renal cell carcinoma
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialists-Broadway Venice, Florida, United States
  • Florida Cancer Specialists West Palm Beach, Florida, United States
  • Hackensack University Medical Center PARTNER Hackensack, New Jersey, United States
View all 36 locations
View Trial Details
Completed

A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer

NCT02960906

Conditions
Clear Cell Metastatic Renal Cell Carcinoma, Clear-cell metastatic renal cell carcinoma
Locations
  • Hôpital Saint André, CHU de Bordeaux Bordeaux, France
  • Centre Francois Baclesse Caen, France
  • CHU Henri-Mondor Créteil, France
  • Centre OSCAR LAMBRET LILLE Lille, France
View all 16 locations
View Trial Details
Completed

Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma

NCT01510119

Conditions
Clear-cell metastatic renal cell carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
Locations
  • University of Medicine and Dentistry of New Jersey New Brunswick, New Jersey, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pittsburgh, Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions